Home Nucleus Medical Devices U.K. Lung Cancer Diagnostics Market to 2032

U.K. Lung Cancer Diagnostics Market to 2032

Overview

The U.K. Lung Cancer Diagnostics Market is expected to reach a 421.29 USD Billion by 2032 and is projected to grow at a CAGR of 20.95% from 2025 to 2032.

Revenue, 2024 (USD Billion)
138.98
Forecast, 2032 (USD Billion)
421.29
CAGR, 2024 - 2032
20.95%
Report Coverage
U.K.

U.K. Lung Cancer Diagnostics Market 2018-2032 USD Billion

U.K. Lung Cancer Diagnostics Market, Key Findings (2025-2032)

Market Growth and Projections:

  • Market Size (2024): 138.98 USD Billion
  • Projected Market Size (2032): 421.29 USD Billion
  • CAGR (2025-2032): 20.95%

Key Findings of U.K. Lung Cancer Diagnostics Market

  • The U.K. Lung Cancer Diagnostics Market was valued at 138.98 USD Billion in 2024.
  • The U.K. Lung Cancer Diagnostics Market is likely to grow at a CAGR of 20.95% during the forecast period of 2024 to 2032.
  • In 2024, the Largest segment Non-Small Cell Lung Cancer in Cancer Segment accounted for the largest share of the market with a revenue of 105.79 USD Billion
  • The fastest growing segment Hospital in End User Segment grew Fastest with a CAGR of 23.93% during the forecast period from 2024 to 2032.

U.K. Lung Cancer Diagnostics Market Scope

U.K. Lung Cancer Diagnostics Market Segmentation & Scope
Distribution Channel
  • Retail Sales
  • Direct Tender
End User
  • Others
  • Cancer Research Institutes
  • Diagnostic Imaging Centers
  • Independent Diagnostic Laboratories
  • Associated Labs
  • Hospital
Cancer
  • Small Cell Lung Cancer
  • Non-Small Cell Lung Cancer
Test
  • Others
  • Blood Test
  • Biopsy
  • Biomarkers Test
  • Imaging Test
Product
  • Consumables & Accessories
  • Instruments

U.K. Lung Cancer Diagnostics Market Data Coverage Insights

Study Period 2024-2032
Base Year 2021
Unit Revenue in USD Billion
Market Value in 2024 138.98 USD Billion
Market Value in 2032 421.29 USD Billion
CAGR (2025-2032) 20.95%
Historic Data 2016-2023
Market Segments Covered Distribution Channel,End User,Cancer,Test,Product

Regional Insights:

  • Leading Market (2024-2032): U.K., leading in terms of revenue 138.98 USD Billion in 2024
    • Key Country: U.K., leading in terms of revenue with value of 138.98 USD Billion in 2024.

Segments and Scope

  • U.K. Lung Cancer Diagnostics Market to 2032, By Distribution Channel
    • Direct Tender is the largest segment in U.K. Lung Cancer Diagnostics Market to 2032 with a revenue of 75.56 USD Billion in the year 2024.
    • Direct Tender is the Fastest growing segment in U.K. Lung Cancer Diagnostics Market to 2032 with a Growth rate of 22.36 % in forecast period 2025-2032.
  • U.K. Lung Cancer Diagnostics Market to 2032, By End User
    • Hospital is the largest segment in U.K. Lung Cancer Diagnostics Market to 2032 with a revenue of 33.44 USD Billion in the year 2024.
    • Hospital is the Fastest growing segment in U.K. Lung Cancer Diagnostics Market to 2032 with a Growth rate of 23.93 % in forecast period 2025-2032.
  • U.K. Lung Cancer Diagnostics Market to 2032, By Cancer
    • Non-Small Cell Lung Cancer is the largest segment in U.K. Lung Cancer Diagnostics Market to 2032 with a revenue of 105.79 USD Billion in the year 2024.
    • Non-Small Cell Lung Cancer is the Fastest growing segment in U.K. Lung Cancer Diagnostics Market to 2032 with a Growth rate of 21.22 % in forecast period 2025-2032.
  • U.K. Lung Cancer Diagnostics Market to 2032, By Test
    • Imaging Test is the largest segment in U.K. Lung Cancer Diagnostics Market to 2032 with a revenue of 66.09 USD Billion in the year 2024.
    • Imaging Test is the Fastest growing segment in U.K. Lung Cancer Diagnostics Market to 2032 with a Growth rate of 22.22 % in forecast period 2025-2032.
  • U.K. Lung Cancer Diagnostics Market to 2032, By Product
    • Instruments is the largest segment in U.K. Lung Cancer Diagnostics Market to 2032 with a revenue of 86.81 USD Billion in the year 2024.
    • Instruments is the Fastest growing segment in U.K. Lung Cancer Diagnostics Market to 2032 with a Growth rate of 21.96 % in forecast period 2025-2032.

U.K. Lung Cancer Diagnostics Market Company Share Analysis

 
Company Name Company Share Analysis
Thermo Fisher Scientific Inc.
Quest Diagnostics Incorporated
Bio-Rad Laboratories, Inc.
Abbott
Guardant Health
U.K. Lung Cancer Diagnostics Market Company Share Analysis

U.K. Lung Cancer Diagnostics Market Geographical Sales Distribution, 2018-2032 USD Billion

U.K. Lung Cancer Diagnostics Market Geographical Sales Distribution, 2018-2032 USD Billion

U.K. Lung Cancer Diagnostics Market Company Profiling

U.K. Lung Cancer Diagnostics Market Company Profiling

Industry Related Reports

South America Hospital Furniture Market
Middle East & Africa Hospital Furniture Market
North America Hospital Furniture Market
Europe Hospital Furniture Market
Asia-Pacific Hospital Furniture Market
Argentina Hospital Furniture Market
Australia Hospital Furniture Market
Belgium Hospital Furniture Market
Brazil Hospital Furniture Market
Canada Hospital Furniture Market
Frequently Asked Questions
The U.K. Lung Cancer Diagnostics Market is segmented based on Segmentation Distribution Channel,End User,Cancer,Test,Product.
U.K. Lung Cancer Diagnostics Market was valued at USD 138.98(Revenue in USD Billion) in 2021.
U.K. Lung Cancer Diagnostics Market is projected to grow at a CAGR of 20.95% during the forecast period of 2024 to 2032.
The Non-Small Cell Lung Cancer segment is expected to dominate the U.K. Lung Cancer Diagnostics Market, holding a largest market share of 105.79 USD Billion in 2024

U.K. Lung Cancer Diagnostics Market Scope

U.K. Lung Cancer Diagnostics Market Segmentation & Scope
Distribution Channel
  • Retail Sales
  • Direct Tender
End User
  • Others
  • Cancer Research Institutes
  • Diagnostic Imaging Centers
  • Independent Diagnostic Laboratories
  • Associated Labs
  • Hospital
Cancer
  • Small Cell Lung Cancer
  • Non-Small Cell Lung Cancer
Test
  • Others
  • Blood Test
  • Biopsy
  • Biomarkers Test
  • Imaging Test
Product
  • Consumables & Accessories
  • Instruments
Frequently Asked Questions
The U.K. Lung Cancer Diagnostics Market is segmented based on Segmentation Distribution Channel,End User,Cancer,Test,Product.
U.K. Lung Cancer Diagnostics Market was valued at USD 138.98(Revenue in USD Billion) in 2021.
U.K. Lung Cancer Diagnostics Market is projected to grow at a CAGR of 20.95% during the forecast period of 2024 to 2032.
The estimated market value of the U.K. Lung Cancer Diagnostics Market for final year is USD 421.29 (USD Billion).

U.K. Lung Cancer Diagnostics Market Company Profiling

U.K. Lung Cancer Diagnostics Market Company Profiling
Frequently Asked Questions
The U.K. Lung Cancer Diagnostics Market is segmented based on Segmentation Distribution Channel,End User,Cancer,Test,Product.
U.K. Lung Cancer Diagnostics Market was valued at USD 138.98(Revenue in USD Billion) in 2021.
U.K. Lung Cancer Diagnostics Market is projected to grow at a CAGR of 20.95% during the forecast period of 2024 to 2032.
The estimated market value of the U.K. Lung Cancer Diagnostics Market for final year is USD 421.29 (USD Billion).

Related Markets

HAVE A QUESTION?

Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.

BROWSE RELATED PAGES